Vestmark Advisory Solutions, Inc.
Position in NTLA — Intellia Therapeutics, Inc.
CIK 1736982
Wakefield, MA
Position in NTLA
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$7,052,845
+$3,061,942 QoQ
Shares Held
550,144
+23.9% QoQ
Ownership
0.394%
of shares outstanding
% of Portfolio
0.19%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2023
10 quarters on record
Voting authority
Sole 69.64067589576547.ToString("F0")%
Shared 30.359324104234524.ToString("F0")%
None 0.ToString("F0")%
Common Shares in NTLA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Vestmark Advisory Solutions, Inc. holds $60,281,695 across 32 Biotechnology names. NTLA ranks #2 (11.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | CRSP |
CRISPR Therapeutics AG
|
256,779 | $12,214,977 | |
| 2 | NTLA |
Intellia Therapeutics, Inc.
This page
|
550,144 | $7,052,845 | |
| 3 | FOLD |
AMICUS THERAPEUTICS, INC.
|
367,153 | $5,309,032 | |
| 4 | BEAM |
Beam Therapeutics Inc.
|
176,865 | $4,214,692 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
9,589 | $3,172,712 | |
| 6 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
6,957 | $3,106,577 | |
| 7 | RXRX |
Recursion Pharmaceuticals, Inc.
|
726,986 | $2,231,847 | |
| 8 | PRAX |
Praxis Precision Medicines, Inc.
|
6,681 | $2,152,551 |
All Filings in NTLA
Export CSV
10 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $7,052,845 | 550,144 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $3,990,903 | 443,927 | Shares | Sole | 2026-02-06 | |
| 2025-09-30 | $5,138,964 | 297,566 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $5,987,647 | 638,342 | Shares | Other | 2025-08-06 | |
| 2025-03-31 | $2,217,481 | 311,882 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $4,375,892 | 375,291 | Shares | Sole | 2025-02-06 | |
| 2024-09-30 | $6,745,455 | 328,246 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $7,952,173 | 355,325 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $11,565,120 | 420,397 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $8,109,760 | 265,981 | Shares | Sole | 2024-02-06 | |
| No filing history on record for this holder in this stock. | ||||||